Core Viewpoint - The company expects a net profit of 6 million to 9 million yuan for the year 2025, a significant recovery from a net loss of 192 million yuan in the same period last year [1] Group 1: Printing Business - The company is enhancing market engagement and collaboration with clients to improve order acquisition capabilities [1] - Internal efforts are focused on quality management and cost reduction to increase efficiency [1] - The printing business is steadily improving, with profits showing growth compared to the previous period [1] Group 2: Technology Education Business - The performance in the technology education sector is still in the process of recovery [1]

格隆汇1月29日丨旗滨集团(601636.SH)公布，经财务部门初步测算，预计2025年度实现归属于母公司所 有者的净利润为5.50亿元到6.70亿元，与上年同期相比，预计增加1.67亿元到2.87亿元，同比增加 43.76%到75.12%。归属于母公司所有者的扣除非经常性损益的净利润为0.85亿元到1.25亿元，与上年同 期相比，预计减少1.64亿元到2.04亿元，同比减少56.69%到70.55%。 ...

每经AI快讯，1月29日，步科股份(688160.SH)公告称，步科股份预计2025年归属于上市公司股东的净利 润为6,800.00万元至8,000.00万元，同比增长39.08%至63.63%。受益于机器人行业需求快速增长，公司 机器人业务营收大幅提升；同时通过精细化运营管理、控费增效，期间费用增速低于收入增速，推动净 利润快速增长。 ...

富临运业公告，预计2025年度净利润为1.65亿元-1.96亿元，同比增长34.99%-60.35%。公司合营企业因 土地收储确认相关非经常性损益。受联营企业盈利增长等因素影响，公司按照权益法核算的投资收益增 加。公司持续推动精益管理，优化费用结构与成本管控，报告期内降本工作取得较好成果。 ...

Core Viewpoint - The company, Huaqiang Technology, anticipates a net profit attributable to shareholders of the parent company for the fiscal year 2025 to be between 32.15 million and 48.20 million yuan, representing a year-on-year increase of 9.62 million to 25.67 million yuan, which translates to a growth rate of 42.70% to 113.94% [1] Group 1 - The company is actively pursuing military product orders, leading to an increase in military product revenue and improved product gross margins [1] - Adjustments in product and market structure have resulted in increased sales of new products, contributing to the enhancement of gross margins for civilian products [1] - Implementation of quality improvement and efficiency enhancement actions, along with cost-saving measures, has yielded effective results, leading to an overall improvement in production management levels [1]

Core Viewpoint - The company expects a net profit for the fiscal year 2025 to be between 44.5 million to 63.1 million yuan, representing a year-on-year growth of 32.31% to 87.62% [1] Financial Performance - The net profit attributable to shareholders is projected to be between 44.5 million to 63.1 million yuan, showing an increase of 32.31% to 87.62% compared to the previous year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 37.373 million to 55.973 million yuan, reflecting a growth of 71.03% to 156.14% year-on-year [1] Factors Influencing Performance - The significant increase in profit is primarily due to the absence of asset impairment losses related to the company's associate, Jiangxi Saiku New Materials Co., Ltd., which recorded a loss of 55.258 million yuan in the same period last year [1] - The company has focused on its core business according to its strategic plan, steadily advancing various business developments and actively exploring domestic and international markets to provide more value-added services to clients [1]

本报告期内，公司公用事业等主营业务保持稳定发展。公司通过联营公司持有的金融资产收益较上年同 期增加，导致公司业绩较上年同期有较大幅度上升。 格隆汇1月29日丨大众公用(600635.SH)公布，经财务部门初步测算，预计2025年年度实现归属于母公司 所有者的净利润为35,000万元到50,000万元，同比增加50.12%到114.46%。预计2025年年度实现归属于 母公司所有者的扣除非经常性损益的净利润为18,500万元到27,500万元，同比变动-10.44%到33.13%。 ...

格隆汇1月29日丨南模生物(688265.SH)公布，经财务部门初步测算，预计2025年年度实现归属于母公司 所有者的净利润为2,400.00万元至3,400.00万元，与上年同期（法定披露数据）相比，将增加1,750.45万 元至2,750.45万元，同比变动比率为269.49%至423.44%。预计2025年年度实现归属于母公司所有者的扣 除非经常性损益的净利润为650.00万元至950.00万元，与上年同期（法定披露数据）相比，将实现扭亏 为盈，增加2,200.96万元至2,500.96万元。 报告期内国内生物医药行业出现回暖迹象，公司工业端营业收入较上年同期增加；通过调整笼位布局、 控制采购价格、优化业务流程等措施持续加强成本管控和提高运营效率。毛利率同比上升，成为公司净 利润增长的核心支撑。 ...

格隆汇1月29日｜晋控电力公告，预计2025年度归属于上市公司股东的净利润为1.55亿元—1.95亿元，同 比上升383.21%—507.90%；扣除非经常性损益后的净利润为1.43亿元—1.83亿元，同比上升276.20%— 325.39%。本报告期业绩预计数与上年同期公告数相比，归属于上市公司股东的净利润同比增加，主要 原因是煤炭价格下降导致公司燃煤采购成本减少。 ...

ST应急公告，预计2025年度净利润为1389.59万元～2084.37万元，同比增长60.81%～141.21%。报告期 内，归属于上市公司股东的净利润同比上升，主要原因：一是多渠道争取外部研发资金，相应减少了自 主研发支出，引起研发费用下降；二是实施可转换公司债券提前赎回，大部分债券转换为股票，引起利 息费用下降，财务费用减少；三是深化成本工程，推进精细化管理，成本控制取得成效。 ...